About: Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 April 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'abril de 2020 (ast) scientific article published on 07 April 2020 (en) наукова стаття, опублікована 7 квітня 2020 (uk)
publication date	wds:Q94488342-39344817-5297-4B52-A1BA-7159C1CB438D
publication date	2020-04-07 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q94488342-044BDE1F-4696-4A76-A8FC-8CB43101E10F
language of work or name	English
cites work	wds:Q94488342-02841EF8-0637-437E-9229-93748BBB7313 wds:Q94488342-050FC860-ED3F-4D65-A839-5B90C26D82A9 wds:Q94488342-0AF01CA7-50A4-4167-8534-0BB49B1D8994 wds:Q94488342-1798BFAA-FFB5-40F6-A4C4-FE10F9DD7946 wds:Q94488342-17D244A4-B32F-4323-9015-2521D7953035 wds:Q94488342-1A99B1F7-5B7F-43CF-BCAF-09560F83DDDA wds:Q94488342-20B2875E-4811-4020-87DB-374779436FFC wds:Q94488342-4255BADD-A3BA-40F3-AE1B-A562609F76F2 wds:Q94488342-5B3951EE-56BF-47F4-A5DF-7A0260ABEF65 wds:Q94488342-5F73A9E0-4800-440F-A3F0-C6283CD755C5 wds:Q94488342-605D7790-7E9B-4A54-A122-E02024226251 wds:Q94488342-76D6B725-C2CB-4714-ADEF-C5FCEE067D8B wds:Q94488342-7FD5F528-E4AC-416F-A9F4-4D852A0C225F wds:Q94488342-AC0F348F-68E8-4523-BA2D-A22C6DB6D249 wds:Q94488342-AD2B3D6D-9750-4001-B3CA-782FCBEB73FB wds:Q94488342-ADF83FEC-CB05-4885-9EA0-50F400E80DAB wds:Q94488342-B7D7DA40-2FD1-4AD4-9247-4FA40B25080F wds:Q94488342-CBE06C30-5D75-464F-A46E-253A137D081F wds:Q94488342-CCA583E1-0D6E-4A78-8F9D-04F9C24AB835 wds:Q94488342-CF84A9EC-5FCC-46BA-8EC3-35D36408E072 wds:Q94488342-DAEC1105-419C-43DA-8C41-113F4B72C676 wds:Q94488342-E0CFE49E-F540-4E58-AAA6-B85564512AFC wds:Q94488342-EE5374B9-E11F-4129-B556-043298E6F0FD wds:Q94488342-F5787B02-41C6-4A8E-A0BA-160315646290 wds:Q94488342-FC669403-287F-4172-8AE2-B5069E1D285D
cites work	In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome Long QT syndrome in adults. Effects of chloroquine on viral infections: an old drug against today's diseases? Long QT syndrome: reduced repolarization reserve and the genetic link Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome Institution-wide QT alert system identifies patients with a high risk of mortality. Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations Azithromycin and risk of sudden cardiac death: guilty as charged or falsely accused? International recommendations for electrocardiographic interpretation in athletes Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine. Determination and Interpretation of the QT Interval Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias. The QT Interval
author name string	wds:Q94488342-448CCBB8-5931-41DA-823B-9F07D2AEEEA3 wds:Q94488342-BC0E042B-4EF0-460C-AF65-3FA3EFC11632 wds:Q94488342-C075FCBC-A10C-42B6-BB6E-CA219029D8B9
author name string	Michael J Ackerman Peter A Noseworthy John R Giudicessi
rdfs:label	Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) (en) Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) (nl)
skos:prefLabel	Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) (en) Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) (nl)
name	Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) (en) Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) (nl)
author	wds:Q94488342-37398515-471B-42AF-9CB9-C9F5FF263F63
author	Paul A Friedman
title	wds:Q94488342-6CE091C7-8388-4BF9-B745-2BDE560E56D9
title	Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) (en)
page(s)	wds:Q94488342-89790702-E4E5-4EFF-A280-1497E2945181
page(s)	1213-1221
instance of	wds:Q94488342-450F706F-FBC8-42B6-80F1-1E037092BD84
instance of	scholarly article
main subject	wds:Q94488342-1D15EA1A-DA10-4BB6-A15A-265D4D35BFBF wds:Q94488342-7648490E-18E9-4CC9-830D-FD74584DFD20
main subject	Coronaviridae COVID-19 mortality
PubMed ID	wds:Q94488342-53B42DED-94AE-40FE-BD78-8CE372153D70
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32359771
PubMed ID	32359771
published in	wds:Q94488342-11A11576-98E9-4FC0-B390-ED418BA75705
published in	Mayo Clin Proc
issue	wds:Q94488342-12B9F4D4-DFA1-4136-B8DF-F457928B1EFE
volume	wds:Q94488342-62D63A2E-D70D-4890-86D9-8AD05EE8E7CF
issue	6
volume	95
DOI	wds:Q94488342-D053AC30-679A-4631-B488-146B41CE7247
DOI	http://dx.doi.org/10.1016/J.MAYOCP.2020.03.024
DOI	10.1016/J.MAYOCP.2020.03.024
Dimensions Publication ID	wds:Q94488342-A768EBCA-907A-4E15-B577-5F3EA9E346F2
Dimensions Publication ID	1126271251
PMCID	wds:Q94488342-06C268B0-5D19-4D55-8609-B48AA6DAB775
PMCID	7141471
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q94488342

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software